The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09

Rheumatology (United Kingdom)

Volumn 52, Issue 11, 2013, Pages 1952-1962

  Cauli, Alberto ^a   Shaw, Jacqueline ^b   Giles, Joanna ^c   Hatano, Hiroko ^b   Rysnik, Oliwia ^b   Payeli, Sravan ^d   McHugh, Kirsty ^c   Dessole, Grazia ^a   Porru, Giovanni ^a   Desogus, Elisabetta ^a   Fiedler, Sarah ^c   Hölper, Soraya ^c   Carette, Amanda ^c   Blanco Gelaz, Miguel Angel ^e   Vacca, Alessandra ^a   Piga, Matteo ^a   Ibba, Valentina ^a   Garau, Pietro ^a   La Nasa, Giorgio ^a   López Larrea, Carlos ^f   Mathieu, Alessandro ^a   Renner, Christoph ^d   Bowness, Paul ^b,c   Kollnberger, Simon ^b   more..

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e Hospital Universitario Central   (Spain)

^f NONE

Author keywords

B27 homodimer; HLA B*27:05; HLA B*27:09; KIR3DL1; KIR3DL2; Spondyloarthritis

Indexed keywords

HLA B27 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; TETRAMER;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURFACE; CLINICAL ARTICLE; FEMALE; HEAVY CHAIN; HLA SYSTEM; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; STAINING; T LYMPHOCYTE;

EID: 84886249418     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket219     Document Type: Article

References (41)

1. Brown MA, Pile KD, Kennedy LG et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 1996;55:268-70.
2. Melis L, Elewaut D. Progress in spondylarthritis immunopathogenesis of spondyloarthritis: which cells drive disease? Arthritis Res Ther 2009;11:233.
3. Kollnberger S, Bird L, Sun MY et al. Cell-surface expression and immune receptor recognition of HLA-B27 homodimers. Arthritis Rheum 2002;46:2972-82.
4. Kollnberger S, Bird LA, Roddis M et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004;173:1699-710.
5. Bird LA, Peh CA, Kollnberger S et al. Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling. Eur J Immunol 2003;33:748-59.
6. Allen RL, O'Callaghan CA, McMichael AJ et al. Cutting edge: HLA-B27 can form a novel beta 2-microglobulinfree heavy chain homodimer structure. J Immunol 1999; 162:5045-8.
7. Kollnberger S, Bowness P. The role of B27 heavy chain dimer immune receptor interactions in spondyloarthritis. Adv Exp Med Biol 2009;649:277-85.
8. Zino E, Di Terlizzi S, Carugo C et al. Rapid detection of all HLA-B*27 alleles (B*2701-B*2725) by group-specific polymerase chain reaction. Tissue Antigens 2004;63: 88-92.
9. D'Amato M, Fiorillo MT, Carcassi C et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995;25: 3199-201.
10. Lopez-Larrea C, Gonzalez-Roces S, Alvarez V. HLA-B27 structure, function, and disease association. Curr Opin Rheumatol 1996;8:296-308.
11. Khan MA, Mathieu A, Sorrentino R et al. The pathogenetic role of HLA-B27 and its subtypes. Autoimmun Rev 2007;6: 183-9.
12. Lanier LL. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 1998;92:705-7.
13. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-74.
14. Kollnberger S, Chan A, Sun MY et al. Interaction of HLAB27 homodimers with KIR3DL1 and KIR3DL2, unlike HLAB27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 2007;37:1313-22.
15. Young NT, Uhrberg M. KIR expression shapes cytotoxic repertoires: a developmental program of survival. Trends Immunol 2002;23:71-5.
16. Ugolini S, Arpin C, Anfossi N et al. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells. Nat Immunol 2001;2:430-5.
17. Chan AT, Kollnberger SD, Wedderburn LR et al. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondyloarthritis. Arthritis Rheum 2005;52:3586-95.
18. Bowness P, Ridley A, Shaw J et al. Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis. J Immunol 2011;186: 2672-80.
19. Brown D, Trowsdale J, Allen R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 2004;64:215-25.
20. Shiroishi M, Kuroki K, Rasubala L et al. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/ CD85d). Proc Natl Acad Sci USA 2006;103:16412-7.
21. Giles J, Shaw J, Piper C et al. HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I. J Immunol 2012; 188:6184-93.
22. Wong-Baeza I, Ridley A, Shaw J et al. KIR3DL2 binds to HLA-B27 dimers and free H chains more strongly than other HLA class I and promotes the expansion of T cells in ankylosing spondylitis. J Immunol 2013;190:3216-24.
23. Payeli SK, Kollnberger S, Marroquin Belaunzaran O et al. Inhibiting HLA-B27 homodimer-driven immune cell inflammation in spondylarthritis. Arthritis Rheum 2012;64: 3139-49.
24. Ramos M, Paradela A, Vazquez M et al. Differential association of HLA-B*2705 and B*2709 to ankylosing spondylitis correlates with limited peptide subsets but not with altered cell surface stability. J Biol Chem 2002;277: 28749-56.
25. Fiorillo MT, Ruckert C, Hulsmeyer M et al. Allele-dependent similarity between viral and self-peptide presentation by HLA-B27 subtypes. J Biol Chem 2005;280:2962-71.
26. Brooks JM, Murray RJ, Thomas WA et al. Different HLAB27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 1993;178:879-87.
27. Nixon DF, Townsend AR, Elvin JG et al. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 1988;336: 484-7.
28. Kvist S, Hamann U. A nucleoprotein peptide of influenza A virus stimulates assembly of HLA-B27 class I heavy chains and beta 2-microglobulin translated in vitro. Nature 1990; 348:446-8.
29. Perosa F, Luccarelli G, Prete M et al. Beta 2-microglobulin- free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide. J Immunol 2003;171:1918-26.
30. Tanabe M, Sekimata M, Ferrone S et al. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I alpha 3 domain. J Immunol 1992;148:3202-9.
31. Martayan A, Sibilio L, Tremante E et al. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells. J Immunol 2009;182:3609-17.
32. McCutcheon JA, Smith KD, Valenzuela A et al. HLAB* 0702 antibody epitopes are affected indirectly by distant antigen residues. Hum Immunol 1993;36:69-75.
33. Schwartz A, Fernandez-Repollet E. Primary performance parameters as quality control indicators. Flow Cytometry Standardization Forum 1994;6:9-10.
34. Dangoria NS, DeLay ML, Kingsbury DJ et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002;277:23459-68.
35. Blanco-Gelaz MA, Suarez-Alvarez B, Diaz-Pena R et al. HLA-B27 polymorphism at position 116 critically influences the association with TAP/tapasin, intracellular trafficking and conformational homodimers formation. Mol Immunol 2009;46:1304-11.
36. Hulsmeyer M, Fiorillo MT, Bettosini F et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 2004;199:271-81.
37. Tsai WC, Chen CJ, Yen JH et al. Free HLA class I heavy chain-carrying monocytes-a potential role in the pathogenesis of spondyloarthropathies. J Rheumatol 2002;29: 966-72.
38. Raine T, Brown D, Bowness P et al. Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology 2006;45:1338-44.
39. Cauli A, Dessole G, Nurchis PP et al. [The role of HLA-B27 molecules in the pathogenesis of ankylosing spondylitis]. Reumatismo 2002;54:266-71.
40. Fussell H, Nesbeth D, Lenart I et al. Novel detection of in vivo HLA-B27 conformations correlates with ankylosing spondylitis association. Arthritis Rheum 2008;58:3419-24.
41. Hillig RC, Hulsmeyer M, Saenger W et al. Thermodynamic and structural analysis of peptide- and allele-dependent properties of two HLA-B27 subtypes exhibiting differential disease association. J Biol Chem 2004;279:652-63.